[Event Report] The 34th Special Breakfast Meeting “2016 Access to Medicine Index” Dr. Jayasree K. lyer (November 24, 2016)
date : 11/24/2016
“34th Special Breakfast Meeting on 2016 Access to Medicine Index” was convened on November 24, 2016, jointly with the Access to Medicine Foundation from the Netherlands.
In this Special Breakfast Meeting, we invited Dr. Jayasree K. lyer, the Executive Director of the Access to Medicine Foundation, which ranks the world’s 20 largest research-based pharmaceutical companies according to their practice in improving access to medicine. This special breakfast meeting became an opportunity to delve into the prospects of Japan’s role and policy agendas as a leader in global health.
In the Q&A session, Dr. Jay and participants had a meaningful and interactive discussions over the “expensive drug pricing mechanism”, “sustainability for the R&D”, and the “future portfolio of Access to Medicine Foundation’s projects”.
Summary of the Event
“Access to medicine” is a fundamental social right that guarantees essential medications and quality healthcare services to those in need. However, there are more than 2 billion people around the world who live beyond the reach of adequate and affordable medicine. In this context, urgent actions at international levels through public private partnerships are imperative. Dr. Jayasree K. lyer of Access to Medicine Foundation presented the newly published 2016 Index, elaborating on its 4 key concepts, 7 technical areas, and 20 detailed company report cards. Through the presentation and Q&A session with the floor, high expectation on Japanese companies was expressed.
*Thank you very much to ATM Foundation for their generous kindness that allow us to share their handouts.
Exhibition date:2016-11-24
Top Research & Recommendations Posts
- [Policy Recommendations] Joint Statement “Protecting the Health of Both the Planet and People — A Japan-Model Planetary Health Strategy to Turn the Climate Crisis into an Opportunity for Health, the Economy, and Growth” (June 24, 2026)
- [Policy Recommendations] Toward Further Advancement of Measures Against Antimicrobial Resistance (AMR) (July 15, 2026)
- [Announcement] HGPI Joins the UHC2030 Task Force for the 2027 UN High-Level Meeting on UHC (July 6, 2026)
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] AMR Policy Update #6: The New Global Action Plan on AMR (Part 1)
- [Research Report] AMR Policy Update #7: The New Global Action Plan on AMR (Part 2)
- [Policy Recommendations] Hearing Loss Project “Recommendations on Coherent Countermeasures for Hearing Loss Throughout the Life Course: Building a Society Where Everyone Can Access Appropriate Hearing Care” (July 30, 2026)
- [Research Report] AMR Policy Update #9: Stockholm Residents’ Awareness and Practices in Returning and Recycling Pharmaceuticals: Findings from Local Interviews (July 15, 2026)
- [Policy Recommendations] Expectations for a System that Spans Diseases, Ministries, and Agencies for the Effective Promotion of Patient and Public Involvement (PPI) in Research and Development (June 30, 2026)
- [Activity Report] HGPI Contributed to the Development of the Civil 7 (C7) Global Health Working Group’s Climate and Health Thematic Brief for the G7 (June 25, 2026)
Featured Posts
-
2026-06-19
[Recommendations] Strengthening Epidemiology Education in the Veterinary Field for the One Health Era (June 19, 2026)
-
2026-07-21
[Announcement] Announcement of the 2nd Kiyoshi Kurokawa Award Recipient
-
2026-07-22
[Registration Open] Second Session of the Planetary Health Academy (Starts September 2026)
-
2026-07-31
[Policy recommendation] Reliable Policy Implementation for Early Detection and Early Intervention of Chronic Kidney Disease (CKD) (July 31, 2026)
-
2026-08-05
[Registration Open] (Webinar) The 4th J-PEP Seminar “The History of PPI in Japan and My Own PPI Journey” (September 30, 2026)



